Integration of Physician and Nursing Professional Efforts to Deliver Supportive Scalp Cooling Care to Oncology Patients at Risk for Alopecia

por Peterson, Lindsay L., Lustberg, Maryam, Tolaney, Sara M., Ross, Mikel, Salehi, Elahe, Isakoff, Steven J.
Publicado 2020

Identification of Novel Pro-Migratory, Cancer-Associated Genes Using Quantitative, Microscopy-Based Screening

por Naffar-Abu-Amara, Suha, Shay, Tal, Galun, Meirav, Cohen, Naomi, Isakoff, Steven J., Kam, Zvi, Geiger, Benjamin
Publicado 2008

Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study

por Isakoff, S J, Wang, D, Campone, M, Calles, A, Leip, E, Turnbull, K, Bardy-Bouxin, N, Duvillié, L, Calvo, E
Publicado 2014

Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic

por Spring, Laura M., Specht, Michelle C., Jimenez, Rachel B., Isakoff, Steven J., Wang, Gary X., Ly, Amy, Shin, Jennifer A., Bardia, Aditya, Moy, Beverly
Publicado 2020

Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer

por McLaughlin, Shannon, Nakajima, Erika, Bar, Yael, Hutchinson, Jennifer A., Shin, Jennifer, Moy, Beverly, Isakoff, Steven J., Bardia, Aditya, Kuter, Irene, Spring, Laura M.
Publicado 2023

A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry

por Smith, Barbara L., Nguyen, Anvy, Korotkin, Jenna E., Kelly, Bridget N., Specht, Michelle C., Spring, Laura M., Moy, Beverly, Isakoff, Steven J., Gadd, Michele A.
Publicado 2020

Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study)

por Isakoff, Steven J., Said, Maya R., Kwak, Agnes H., Glieberman, Eva, O’Rourke, Emily A., Stroiney, Amanda, Spring, Laura M., Moy, Beverly, Bardia, Aditya, Horick, Nora, Peppercorn, Jeffrey M.
Publicado 2023

A Phase II Trial of Cabozantinib in Hormone Receptor‐Positive Breast Cancer with Bone Metastases

por Xu, Jing, Higgins, Michaela J., Tolaney, Sara M., Come, Steven E., Smith, Matthew R., Fornier, Monica, Mahmood, Umar, Baselga, Jose, Yeap, Beow Y., Chabner, Bruce A., Isakoff, Steven J.
Publicado 2020

Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort

por Swaroop, Meyha N., Ferguson, Chantal M., Horick, Nora K., Skolny, Melissa N., Miller, Cynthia L., Jammallo, Lauren S., Brunelle, Cheryl L., O’Toole, Jean A., Isakoff, Steven J., Specht, Michelle C., Taghian, Alphonse G.
Publicado 2015

Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer

por Spring, Laura M., Clark, Shealagh L., Li, Tianyu, Goel, Shom, Tayob, Nabihah, Viscosi, Elene, Abraham, Elizabeth, Juric, Dejan, Isakoff, Steven J., Mayer, Erica, Moy, Beverly, Supko, Jeffrey G., Tolaney, Sara M., Bardia, Aditya
Publicado 2021

Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer

por Spring, Laura M., Han, Hyo, Liu, Minetta C., Hamilton, Erika, Irie, Hanna, Santa-Maria, Cesar A., Reeves, James, Pan, Peng, Shan, Ming, Tang, Yongqiang, Graham, Julie R., Hazard, Sebastien, Ellisen, Leif W., Isakoff, Steven J.
Publicado 2022

Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer

por Spring, Laura M., Han, Hyo, Liu, Minetta C., Hamilton, Erika, Irie, Hanna, Santa-Maria, Cesar A., Reeves, James, Pan, Peng, Shan, Ming, Tang, Yongqiang, Graham, Julie R., Hazard, Sebastien, Ellisen, Leif W., Isakoff, Steven J.
Publicado 2022

A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rati...

por Isakoff, Steven J, Puhalla, Shannon, Domchek, Susan M, Friedlander, Michael, Kaufman, Bella, Robson, Mark, Telli, Melinda L, Diéras, Véronique, Han, Hyo Sook, Garber, Judy E, Johnson, Eric F, Maag, David, Qin, Qin, Giranda, Vincent L, Shepherd, Stacie P
Publicado 2017

Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomize...

por Turner, Nicholas, Dent, Rebecca A., O’Shaughnessy, Joyce, Kim, Sung-Bae, Isakoff, Steven J., Barrios, Carlos, Saji, Shigehira, Bondarenko, Igor, Nowecki, Zbigniew, Lian, Qinshu, Reilly, Sarah-Jayne, Hinton, Heather, Wongchenko, Matthew J., Kovic, Bruno, Mani, Aruna, Oliveira, Mafalda
Publicado 2021

An Initial Evaluation of Human Plasma cMLC-1: A Potential Protein Biomarker for Trastuzumab-Induced Cardiotoxicity, Breast Cancer Screening and Progression

por Yu, Ling, Allen, Read, Jia, Lin, Sun, Ting, Isakoff, Steven J., Scherrer-Crosbie, Marielle, Kehlmann, Allison M., Zheng, Hui, Ly, Amy, Walmsley, Charlotte S., Hesler, Katherine, Varasteh, Ava N., Pinto, Christopher J., McLoughlin, Daniel E., Wu, Wenjin, Wang, Xinhui
Publicado 2022

Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT)

por Sella, Tal, Zheng, Yue, Tayob, Nabihah, Ruddy, Kathryn J., Freedman, Rachel A., Dang, Chau, Yardley, Denise, Isakoff, Steven J., Valero, Vicente, DeMeo, Michelle, Burstein, Harold J., Winer, Eric P., Wolff, Antonio C., Krop, Ian, Partridge, Ann H., Tolaney, Sara M.
Publicado 2022

PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer

por Nixon, Mellissa J., Formisano, Luigi, Mayer, Ingrid A., Estrada, M. Valeria, González-Ericsson, Paula I., Isakoff, Steven J., Forero-Torres, Andrés, Won, Helen, Sanders, Melinda E., Solit, David B., Berger, Michael F., Cantley, Lewis C., Winer, Eric P., Arteaga, Carlos L., Balko, Justin M.
Publicado 2019

RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer

por Koh, Siang-Boon, Ross, Kenneth, Isakoff, Steven J., Melkonjan, Nsan, He, Lei, Matissek, Karina J., Schultz, Andrew, Mayer, Erica L., Traina, Tiffany A., Carey, Lisa A., Rugo, Hope S., Liu, Minetta C., Stearns, Vered, Langenbucher, Adam, Saladi, Srinivas Vinod, Ramaswamy, Sridhar, Lawrence, Michael S., Ellisen, Leif W.
Publicado 2021

Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

por Shi, Zhen, Wulfkuhle, Julia, Nowicka, Malgorzata, Gallagher, Rosa I., Saura, Cristina, Nuciforo, Paolo G., Calvo, Isabel, Andersen, Jay, Passos-Coelho, José Luis, Gil-Gil, Miguel J., Bermejo, Begoña, Pratt, Debra A., Ciruelos, Eva M., Villagrasa, Patricia, Wongchenko, Matthew J., Petricoin, Emanuel F., Oliveira, Mafalda, Isakoff, Steven J.
Publicado 2022

Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer

por Coates, James T., Sun, Sheng, Leshchiner, Ignaty, Thimmiah, Nayana, Martin, Elizabeth E., McLoughlin, Daniel, Danysh, Brian P., Slowik, Kara, Jacobs, Raquel A., Rhrissorrakrai, Kahn, Utro, Filippo, Levovitz, Chaya, Denault, Elyssa, Walmsley, Charlotte S., Kambadakone, Avinash, Stone, James R., Isakoff, Steven J., Parida, Laxmi, Juric, Dejan, Getz, Gad, Bardia, Aditya, Ellisen, Leif W.
Publicado 2021